Emdogain Minimally Invasive Surgical Technique



Status:Active, not recruiting
Conditions:Dental
Therapuetic Areas:Dental / Maxillofacial Surgery
Healthy:No
Age Range:21 - 85
Updated:3/31/2019
Start Date:October 2015
End Date:July 2019

Use our guide to learn which trials are right for you!

Straumann® Emdogain® Application In Conjunction With Minimally Invasive Surgical Technique For Periodontal Disease Treatment: A Split-Mouth Design Study

The aim of this controlled study is to assess the clinical outcomes and patient reported
outcomes of using minimally invasive surgical procedure with Straumann Emdogain as an adjunct
(test treatment) or without Straumann Emdogain (control treatment).

The aim of the study will be achieved through the following primary and secondary objectives.
The primary objective is to evaluate the regenerative potential of Straumann Emdogain by
comparing the change in clinical attachment level from baseline to 12 months between the test
and control arms. The regenerative potential of Straumann Emdogain will also be assessed by
comparing the changes in gingival margins, changes in average probing pocket depth, changes
in full mouth plaque score, changes in bleeding on probing, and changes in root dentin
hypersensitivity from baseline to 12 months between the test and control arms.

Inclusion Criteria:

- Subjects must have voluntarily signed the informed consent form before any study
related procedures

- Subjects must be males or females who are 18-85 years of age

- Subjects must have moderate to severe chronic, generalized periodontitis with pockets
of 5 mm - 8mm probing depth in at least 2 pockets per contralateral quadrants in one
arch (study teeth)

- Subjects must be committed to the study and the required follow-up visits

- Subjects must be in good general health as assessed by the Investigator

Exclusion Criteria:

- Subjects taking or intending to take any medications during the duration of the study
that will potentially affect healing and inflammation

- Subjects who are currently heavy smokers (defined >10 cigarettes per day or >1 cigar
per day) or who use chewing tobacco

- Subjects being treated with systemic antibiotics or subjects that were treated with
systemic antibiotics within 3 months prior to treatment in this study

- Subjects with uncontrolled diabetes

- Subjects that are immunocompromised or immunosuppressed

- Subjects that cannot provide informed consent

- Subjects with drug or alcohol abuse

- Subjects that have undergone periodontal root planing or periodontal surgery in the
last 6 months

- Subjects that are pregnant

- Subjects with necrotizing periodontitis or periodontitis related to systemic disease

- Teeth with pockets with probing depth ≥ 9 mm will not classify as study teeth

- Teeth with pockets or defects with furcation involvement will not classify as study
teeth

- Teeth with mobility degree > 1 without splint will not classify as study teeth

- Subjects with test and control sites in the two quadrants on adjacent teeth

- Patients with compromised health conditions such as diabetes, systemic diseases, high
dose steroid therapy, bone metabolic diseases, radiation or immune-oppressive therapy,
and infections or vascular impairment at the surgical site

- Subjects with conditions or circumstances, in the opinion of the Investigator , which
would prevent completion of study participation or interfere with analysis of study
results
We found this trial at
3
sites
Montreal, Quebec
Phone: 514-303-7276
?
mi
from
Montreal,
Click here to add this to my saved trials
Aurora, Colorado 80012
Phone: 303-696-7885
?
mi
from
Aurora, CO
Click here to add this to my saved trials
Cullman, Alabama 35055
Phone: 256-734-8588
?
mi
from
Cullman, AL
Click here to add this to my saved trials